DelveInsight’s, “ Small Lymphocytic Lymphoma Pipeline Insight, 2025 ” report provides comprehensive insights about 80+ ...

Amgen's expanding rare disease and biosimilar portfolios, coupled with growth potential and dividend history make AMGN stock ...

DelveInsight’s, “Diabetes Pipeline Insight 2025” report provides comprehensive insights about 200+ companies and 200+ ...

Despite some near-term revenue growth, HRTX's future is uncertain. Click here to find out why HRTX stock is a Hold.

Pipelines are the critical infrastructure that underpins global energy trade and geopolitical power, and these nine projects ...

Bloomberg's Mark Gurman breaks down the new hardware set to be released by Apple in 2026 including new Macs, iPads, an iPhone ...

Group net sales grow by 6.3%* to EUR 14.0 billion, driven by Human Pharma (EUR 11.3 billion) and Animal Health (EUR 2.6 billion)Regulatory submissions underway for zongertinib and nerandomilast, with ...

The Refined Petroleum Products Pipeline Transport Market is set to soar from USD 47 billion in 2025 to USD 80.4 billion by 2034, with a CAGR of 6.1%. Driven by technological advancements ...

A strong technology backbone also enables the growing importance of GCCs in product ownership. Embracing cloud-based ...

Healthcare product and device company Abbott Laboratories (NYSE:ABT) in Q2 CY2025, with sales up 7.4% year on year to $11.14 ...

More than thirty years since its 1993 founding, Catherine Owen Adams and Elizabeth Thompson—the R&D combo that has led Acadia ...

Operating expenses declined 28%, reducing net loss to $21.5 million (GAAP). Record backlog reached $12.5 million, up 155 %, but management did not offer quantitative 2026 guidance.